1. The economic pressures for biosimilar drug use in cancer medicine;Cornes;Target Oncol,2012
2. Prices, costs, and affordability of new medicines for hepatitis c in 30 countries: an economic analysis;Iyengar;PLoS Med,2016
3. Pharmaceutical policies in European countries;Barros,2010
4. Overview of external reference pricing systems in Europe;Remuzat;J Mark Access Health Policy,2015
5. Toumi M, Rémuzat C, Vataire AL, Urbinati D. (2013) External reference pricing of medicinal products: simulation-based considerations for cross-country coordination. European Commission report. European Union. Available at: http://ec.europa.eu/health/systems_performance_assessment/docs/erp_reimbursement_medicinal_products_en.pdf (accessed: November 2016)